Patient Rating:

4.8 out of 5

147 Patient Ratings
52 Patient Comments

William Lowrance, M.D., M.P.H.

Clinical Details

Locations

Schedule An Appointment Clinical Office Address
(801) 587-4381 Huntsman Cancer Hospital
Clinic 2B, GU
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

William Lowrance, MD, MPH, is an assistant professor in the Division of Urology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. He specializes in the surgical treatment of urologic malignancies. His practice at the Huntsman Cancer Institute primarily focuses on treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer. He has extensive training and experience with open, laparoscopic, and robotic surgical techniques. His research efforts focus on understanding and improving clinical outcomes for patients with urologic cancers. Dr. Lowrance has published numerous peer-reviewed urologic articles, book chapters, and editorials. He is member of the American Urological Association’s Advanced Prostate Cancer Clinical Guidelines committee and serves on the editorial board for multiple medical journals. He peer reviews medical manuscripts for over 10 different medical journals. Additionally, he has received a National Institutes of Health Challenge grant for studying the differences between open and robotic radical prostatectomy.

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Urology
Board Certification American Board of Urology
Cancer Center Programs Cancer Control & Population Sciences

Patient Ratings

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending doctor
4.8
My confidence in doctor
4.8
Time doctor spent with me
4.7
Doctor spoke using clear language
4.8
Doctor's effort to include me in decisions
4.8
Doctor's concern for questions & worries
4.8
Doctor's explanation of condition/problem
4.8
Wait time at clinic
4.1
Doctor's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

March 13, 2014

Dr Lowrance is an absolutely outstanding physician and most of all one of the nicest people I ever meet.

February 15, 2014

I truly felt I was in good hands and being cared for by people who really care.

January 20, 2014

good

January 07, 2014

We have no complaints at all about Huntsman staff. It seems as if Huntsman staff is set apart and above, from some other medical institutions that we have been involved in.

January 06, 2014

have let other people know how great our time down here has been

November 18, 2013

This is the best care provider I have ever been to.

November 13, 2013

Everything else were great except Q.4. I felt at times I was not included.

October 29, 2013

Dr Lowrance is the best!

October 21, 2013

Dr. Lowrance exceeded my expectations for an academic specialist.

October 21, 2013

Unable to tell me why I am experiencing the symptoms that I am. Focused only on the cancer.

September 24, 2013

The Care Provider stayed through the whole prcedure

September 23, 2013

Dr. Lawrance and staff are really a great bunch of individuals, they care about what they are doing.

September 22, 2013

Never were we rushed or cut short. The care is above and beyond !

August 17, 2013

very nice and informative

July 16, 2013

Way to long to wait in the exam room

July 09, 2013

this clinic is seriously overbooked.

July 07, 2013

felt that the staff was concerned and engaged

June 24, 2013

Everyone involved provided excellent care, information, and treatment.

June 18, 2013

it was a good experience all together

June 17, 2013

felt better about things when we left had some issues explained and set our mind at ease

June 04, 2013

I was quite relieved and satisfied with what I was told. The visual of my CT scan was educational and I like being treated like an educated adult.

May 22, 2013

All my experience was very positive from beginning to end, I talked to very acknowledgeable, intelligent, caring people.

April 21, 2013

the doctor was very informative about helping us make the decisions we needed to make.

April 09, 2013

great experince

April 08, 2013

Fell very confident in Dr Lowrence.

March 18, 2013

I feel that I have always been treated with courtesy and thoughtful concern. There are not many bright spots in dealing with cancer...there are indeed very few. But being at the Huntsman is one of those bright moments. I am grateful to have access to the Huntsman Cancer Institute.

March 16, 2013

Impressed with how well the staff cared about each person involved.

February 21, 2013

Y'know, when you're told that you don't have cancer, it's pretty hard to say anything bad about your visit.

February 20, 2013

I was nervous about going to a different doctor and treatment center. However, after arriving I was treated courteously and respectfully. I appreciate it.

February 11, 2013

Dr. Lowrance explained the going-forward treatment options and answered all questions for both my wife and I. Patrick the resident, was also very informative.

January 30, 2013

Dr. LOWRANCE is extremely gentle & caring. He is AWESOME!

January 21, 2013

Dr. Lowrance was excellent!

January 07, 2013

Very good

January 01, 2013

The attending physicians and the assisting personnel were excellent. They introduced themselves and were genuine in their efforts to assist me through the process.

December 31, 2012

Good experience

December 30, 2012

Very good. I would recommend this facility and the staff to everyone!

December 18, 2012

I would like to have spent more time, which is probably common. The time I had was sufficient. I realize the doctor has other patients to see.

December 10, 2012

we love Dr. Lowrance. he has been so helpful and willing to discuss anything and making sure we understand and that we do not have any questions

December 05, 2012

I can't say enough good about your staff they do a wonderful job. I highly recommend your facility to others. We have been ask often where they should go my family and myself explain in detail why they should go to your facility.

November 19, 2012

god experience

November 07, 2012

Outstanding medical professionals!

October 14, 2012

Outstanding care and direction

October 10, 2012

liked how doctor explained everything well

October 08, 2012

We feel fortunate to have Dr. Lowrance. Excellent doctor.

October 02, 2012

Dr Lowrance was superior in all aspects

August 21, 2012

Dr Lowrence was excellent

March 24, 2012

I am very impressed with all providers.

March 24, 2012

All very good!

March 17, 2012

Dr. Lowrance is an excellent doctor and I feel very fortunate to be under his care.

March 03, 2012

Really appreciate the time the doctor took to go over the medical history. Spent a lot of time explaining things.

March 03, 2012

They just didn't do what they told us was going to happen. It was postponed to a later surgery date. We felt that this caused us an extra trip to SLC, over 400 miles one way plus overnights.

February 18, 2012

I really appreciated the Dr's expertise and his ability to answer all my questions. I am a professor of physics at UofU with a good understanding of anatomy and biology as well and I greatly appreciated the Dr's detailed responses ultimately in reasonably technical terms that greatly enchanced my understanding of my situation.

Academic Profile

Research Interests

  • Renal Cancer
  • Urothelial Cancer
  • Cancer Clinical Genetics Communication
  • Testicular Cancer
  • Prostate Cancer
  • Cancer Genetics
  • Health Services Research
  • Bladder Cancer
  • Chronic Kidney Disease and Cancer Risk

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Urology
Board Certification American Board of Urology
Cancer Center Programs Cancer Control & Population Sciences

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 587-4282 Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

William Lowrance, MD, MPH, is an assistant professor in the Division of Urology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. Dr. Lowrance is co-leader of the HCI Prostate Disease Oriented Team and a member of the HCI Cancer Control and Population Sciences program. He specializes in the surgical treatment of urologic malignancies. His practice at the Huntsman Cancer Institute primarily focuses on treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer. He has extensive training and experience with open, laparoscopic, and robotic surgical techniques.

His research efforts focus on understanding and improving clinical outcomes for patients with urologic cancers. As a clinical outcomes researcher, he has conducted comparative effectiveness studies of outcomes between robotic and open radical prostatectomy. He also studies the cost and patterns of care, as well as disparities in treatment delivery of various genitourinary malignancies. He is investigating a possible link between chronic kidney disease and renal cancer. In addition to his health services research, he designs and conducts clinical trials studying novel approaches for the treatment of prostate, kidney, and bladder cancer.

Dr. Lowrance has published numerous peer-reviewed urologic articles, book chapters, and editorials. He is member of the American Urological Association’s Advanced Prostate Cancer Clinical Guidelines committee and serves on the editorial board for the medical journals, Urologists in Cancer Care and Frontiers in Genitourinary Oncology. He peer reviews medical manuscripts for over 10 different medical journals. Additionally, he has received a National Institutes of Health Challenge grant for studying the differences between open and robotic radical prostatectomy.

Dr. Lowrance completed his medical degree at the Medical University of South Carolina in Charleston, SC. Following medical school, he completed a General Surgery internship and Urology residency at Vanderbilt University Medical Center in Nashville, TN. He then completed a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York, NY. During this time, he also earned a masters degree in public health from Harvard University.

Education

Education History

Type School Degree
Graduate Training Harvard School of Public Health
Summer Program in Clinical Effectiveness
M.P.H.
Fellowship Memorial Sloan-Kettering Cancer Center
Urologic Oncology
Fellow
Chief Resident Vanderbilt University Medical Center
Urology
Chief Resident
Residency Vanderbilt University Medical Center
Urology
Resident
Professional Medical Medical University of South Carolina
Medicine
M.D.
Undergraduate Washington and Lee University
Chemistry, Summa cum laude
B.A.

Publications

Selected Provider Publications

Journal Article

  1. O'Neil B.B, Preston A., Gannon J., Stephenson R.A., Lowrance W., Dechet C.B., Tward J.D., Myers J.B., Brant W.O.(2014)Climacturia after definitive treatment of prostate cancer.  Journal of Urology, 191(1),159-163
  2. Myers JB, Taylor MB, Brant WO, Lowrance W, Wallis MC, Presson AP, Morris SE, Nirula R, Stevens M(2013)Process improvement in trauma: traumatic bladder injuries and compliance with recommended imaging evaluation.  The Journal of Trauma and Acute Care Surgery, 74(1),264-9
  3. Hardee MJ, Lowrance W, Brant WO, Presson AP, Stevens MH, Myers J(2013)High grade renal injuries: application of Parkland Hospital predictors of intervention for renal hemorrhage.  Journal of Urology, 189(5),1771-6
  4. Christensson A, Savage C, Sjoberg DD, Cronin AM, Frank O'Brien M, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja (2013)Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.  International Journal of Cancer (electronic), 133(6),1452-8
  5. Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo R(2013)A review of contemporary data on surgically resected renal masses-benign or malignant?  Urology, 81(4),707-13
  6. Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS(2013)Castration-Resistant Prostate Cancer: AUA Guidelines.  Journal of Urology, Aug 190(2),429-38
  7. Aviva G. Asnis-Alibozek, PA-C, Michael J. Fine, MD, Paul Russo, MD, Trent McLaughlin, BSc(Pharm), PhD, Eileen M. Farrelly, MPH, Norman LaFrance, MD , William T. Lowrance, MD, MP(2013)Cost of Care for Malignant and Benign Renal Masses  American Journal of Managed Care, The, 19(8),617-624
  8. O'Neil B.B, Lowrance W(2013)Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques.  Urologic Clinics of North America,
  9. Hardee MJ, Lowrance W, Stevens MH, Nirula R, Brant WO, Morris SE, Myers J(2013)Process improvement in trauma: compliance with recommended imaging evaluation in the diagnosis of high-grade renal injuries  The Journal of Trauma and Acute Care Surgery, 74(2),558-62
  10. Myers JB, Taylor MB, Brant WO, Lowrance WT, Wallis MC, Presson AP, Morris SE, Nirula R, Stevens M(2013)Process improvement in trauma: traumatic bladder injuries and compliance with recommended imaging evalutaion  The Journal of Trauma and Acute Care Surgery, jan 2013 7(1),264-9
  11. Silberstein JL, Poon SA, Maschino AC, Lowrance WT, Garg T, Herr HWm Donet SM, Dalbagni G, Bochner BH, Sandhu J(2013)Urinary diversion practice patterns among certifying Americans urologist  Journal of Urology, 189(3),1042-7
  12. Lowrance WT, Eastham JA, Savage C, Maschino AC, Laudone VP, Dechet CB, Stephenson RA, Scardino PT, Sandju JS(2012)Contemporary Open and Robotic Radical Prostatectomy Practice Patterns Among Urologist in the United States.  Journal of Urology,
  13. Lowrance WT, Southwick A, Maschino AC, Sandhu J(2012)Contemporary Practice Patterns of Endoscopic Surgical Management for Benign Prostatic Hyperplasia Among Urologists in the United States  Journal of Urology,
  14. Bolenz C, Freedland SJ, Hollenbeck BK, Lotan Y, Lowrance WT, Nelson JB, Hu J(2012)Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review  European Urology, Sep 5 2012
  15. Mirkin JN, Lowrance WT, Feifer AH, Mulhall JP, Wastham JE, Elkin EB(2012)Direct-to-consumer internet promotion of robtoic prostatectomy exhibits varying of information.  Health Affairs (Project Hope),
  16. Lowrance WT, Elkin EB, Yee DS, Feifer A, Ehdaie B, Jacks LM, Atoria CL, Selefsky MJ, Scher HI, Scardino PT, Eastham JA(2012)Locally advanced prostate cancer: a population-based study of treatment patterns.  BJU International, 109(9),1309-1314
  17. Poon SA. Silberstein JL, Savage C, Maschino AC. Lowrance WT, Sandhu JS(2012)Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologist.  Journal of Urology, jul 2012(188),205-10
  18. Lim A, O'Neil B, Heilbrun ME, Dechet C, Lowrance W(2012)The contemporary role of renal mass biopsy in the management of small renal tumors.  Frontiers in Oncology, 2012(2),106
  19. Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo (2011)Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.  Journal of Urology, 185(1),37-42
  20. Adamy A, Lowrance WT, Yee DS, Chong KT, Bernstein M, Tickoo SK, Coleman JA, Russo (2011)Renal oncocytosis: management and clinical outcomes.  Journal of Urology, 185(3),795-801
  21. Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham J(2011)Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.LID - 10.1002/cncr.25981 [doi]  Cancer,
  22. Ehdaie B, Chromecki TF, Lee RK, Lotan Y, Margulis V, Karakiewicz PI, Novara G, Raman JD, Ng C, Lowrance WT, Scherr DS, Shariat S(2011)Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.  Journal of Urology, 186(1),66-72
  23. Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin E(2011)Ethnic differences in bladder cancer survival.  Urology, 78(3),544-9
  24. Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin E(2011)Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis.LID - 10.1002/cncr.26609 [doi]  Cancer,
  25. Ehdaie B, Atoria CL, Gupta A, Feifer A. Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB(2011)Androgen deprivation and thromboembolic events in men with prostate cancer surgery. A population-based analysis.  Cancer,
  26. Ehdaie B, Maschino A, Shariat SF, Rioja J, Hamitlon RJ, Lowrance WT, Poon SA, Al-Ahmadie HA, Herr HW(2011)Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.  Journal of Urology, 187(1),74-9
  27. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo (2010)Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.  BJU International, 105(1),16-20
  28. Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani (2010)Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.  BJU International, 105(2),185-90
  29. Lowrance WT, Elkin EB, Scardino PT, Eastham J(2010)Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy.  European Urology, 57(3),538
  30. Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT, Eastham J(2010)Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.  Journal of Urology, 183(4),1366-72
  31. Dulabon LM, Lowrance WT, Russo P, Huang W(2010)Trends in renal tumor surgery delivery within the United States.  Cancer, 116(10),2316-21
  32. Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G, Sandhu J(2010)Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.  Journal of Urology, 183(5),1751-6
  33. Lowrance WT, Yee DS, Savage C, Cronin AM, O'Brien MF, Donat SM, Vickers A, Russo (2010)Complications after radical and partial nephrectomy as a function of age.  Journal of Urology, 183(5),1725-30
  34. Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham J(2010)Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.LID - 10.1111/j.1464-410X.2010.09848.x [doi]  B J U International,
  35. Boudreaux KJ Jr, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Chang S(2009)Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.  Journal of Urology, 181(2),540-5; discussion 546
  36. Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, Galvin D, Dalbagni G, Touijer K, Russo (2009)Contemporary use of partial nephrectomy at a tertiary care center in the United States.  Journal of Urology, 181(3),993-7
  37. Boudreaux KJ Jr, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Clark P(2009)Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.  Cancer, 115(4),770-5
  38. Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo (2009)Developments in the surgical management of sporadic synchronous bilateral renal tumours.  BJU International,
  39. Lowrance WT, Rumohr JA, Clark PE, Chang SS, Smith JA Jr, Cookson M(2009)Urinary diversion trends at a high volume, single American tertiary care center.  Journal of Urology, 182(5),2369-74
  40. Lowrance WT, Scardino P(2009)Predictive models for newly diagnosed prostate cancer patients.  Reviews in Urology, 11(3),117-26
  41. Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA Jr, Cookson M(2008)Contemporary open radical cystectomy: analysis of perioperative outcomes.  Journal of Urology, 179(4),1313-8; discussion 1318
  42. Jung C, DeMarco RT, Lowrance WT, Pope JC 4th, Adams MC, Dietrich MS, Brock JW 3r(2007)Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.  Journal of Urology, 177(1),312-5
  43. Lowrance WT, Cookson MS, Clark PE, Smith JA Jr, Chang S(2007)Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs.  Journal of Urology, 178(2),500-3; discussion 503

Review

  1. Lowrance WT, Tarin TV, Shariat S(2010)Evidence-based comparison of robotic and open radical prostatectomy.  Scientific World Journal, The, 102228-37
  2. Lowrance WT, Chang SS, Herrell S(2006)Primary renal carcinoid tumor managed with laparoscopic partial nephrectomy.  Urology, 67(3),622.e19-20
  3. Lowrance WT, Chang S(2006)Advancing prostate cancer: treatment options for the urologist.  Urologic Clinics of North America, 33(2),211-7, vii

Book Chapter

  1. O'Neil BB, Lowrance WT(2013)Office-based Bladder of Tumor Fulguration and Surveillance: Indications and Techniques.  , 40 (2)175-82
  2. Lowrance WT, Sheinfeld (2011)Radical Orchiectomy and Retropertioneal Lymph Node Dissection  ,
  3. Lowrance WT, Chang SS, Cookson M(2007)Urothelial Carcinoma.  ,

Editorial

  1. Lowrance W(2013)discussion  , 189(3),2203-4
  2. Lowrance WT, Parekh D(2011)The rapid uptake of robotic prostatectomy and its collateral effects.LID - 10.1002/cncr.26275 [doi]  Progress in Inflammatory Bowel Disease,
  3. Lowrance W(2010)Surgical margins following urological cancer surgery and clinical outcomes--does the United States need regional centralization of cancer care?  Utah Special Educator, 183(6),2126-7

Letter

  1. Lowrance WT, Elkin EB, Eastham J(2010)Minimally invasive vs open radical prostatectomy.  JAMA: The Journal of the American Medical Association, 303(7),619-20; author reply 620

Clinical Trials

Video & News

Video